Abstract:Objective To evaluate the efficacy of patients with stage T2 bladder cancer who underwent combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy.Methods The survival data of bladder cancer paients from January 2000 to December 2014 with stage T2N0M0 were retrospectively analyzed.Thirty-five patients of cT2N0M0 receive combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy(group A),and 80 patients of pT2N0M0 underwent radical cystectomy (RC) (group B).The pathological diagnosis of all patients was urothelial carcinoma.In group A,there were 33(94.2％) males and 2 (5.8％) females;20 (57.1％) tumor size less than 3 cm and 15 (42.9％) larger than 3 cm;24 (68.6％) with single tumor and 11 (31.4％) with multiple tumors;11 (31.4％) patients with primary tumors and 24 (68.6％) recurrent tumors.In group B,there were 71 (88.7％) males and 9 (11.3％) females;35 (43.8％) tumor size less than 3 cm and 45(56.2％) larger than 3 cm;44 (55.0％) with single tumors and 36 (45.0％) with multiple tumors;22(27.5％) patients with primary tumors and 58 (72.5％) recurrent tumors.Results Groups A and B consisted of 35 and 80 patients and median follow-up time was 68 (13-157)and 67 (4-198)months,respectively.There was no significantly statistical difference in disease-specific survival (DSS) between the two groups(P =0.888),76.5％ for group A and 60.6％ for group B respectively.In group A,26 (74.3％) patients achieved complete response (CR) to intra-arterial chemotherapy.Additionally,amounts of 21 (60.0％) patients preserve their functional bladder successfully and their median follow-up time was 69 (13-134)months.8 patients receive delayed radical cystectomy when suffered tumor recurrence and none of them had lymph node metastases.Of those pathological stage was presented as stage T2 5 cases,T3 2 cases and T4 1 case.Importantly,the 8 patients who receive delayed RC did not confer worse DSS when compared with those underwent immediate RC in group B (P =0.809).Cox proportional hazards model showed that tumor number and CR to intra-arterial chemotherapy was independent prognostic factor for disease-free survival (HR =0.238,P =0.007) and DSS(HR =0.085,P =0.004) respectively.During the period of intra-arterial chemotherapy,we did not observe hematological toxicity of grade Ⅳ and the hematological toxicity of grade Ⅰ-Ⅲ was 9 (25.7％),6 (17.1％) and 4 (11.4％).Conclusions For patients with T2N0M0,combined treatment of bladder-preserving surgery and adjuvant intra-arterial chemotherapy could be a therapy with long-term survival outcome and safety.The therapy could be offered as alternative treatment option for patients who were unsuitable for receiving RC.

Bladder preservation and intravesical therapy for bladder cancer

Combined Modality Therapy Following Bladder Conservation Surgery for Bladder Cancers

The outcome of bladder-sparing surgery combined with intra-arterial chemotherapy for invasive bladder cancer

Bladder Preservation by Internal Iliac Arterial Infusion Chemotherapy and Radiotherapy in Invasive Bladder Carcinoma

A Role of Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer Plus Hydronephrosis with or Without Pelvic Nodal Involvement.

The clinical study of intra-arterial chemotherapy followed by bladder-preserving surgery for high-risk non muscle-invasive bladder cancer

[Comprehensive Therapy of Bladder Preservation for Muscle Invasive Bladder Cancer].

Postoperative Radiotherapy Combined with Cisplatin Intravesical Infusion to Prevent Relapse in Invasive Bladder Cancer

Combined-Modality Treatment for High Risk TCC of the Bladder

Management of Primary T1G3 Bladder Cancer: Immediate Cystectomy or Bladder Preserving Approach?

Bladder-conserving Therapy for Muscle Invasive Bladder Cancer: Current Status and Future

Surgical Treatment for 217 Patients with Bladder Transitional Carcinoma

[Selective Bladder Preservation in Muscle-Invasive Bladder Cancer by Transurethral Resection Combined with Intravesical Instillation Therapy: Analysis of Clinical Effect in the Elderly].

Effect of Post Bladder Sparing Operation Intra-Arterial Chemotherapy Combined with Intravesical Chemotheraoy for the Treatment of T1G3 Bladder Urothelial Carcinoma

Surgical treatment for single pT2 bladder transitional carcinoma

Analysis of the outcomes and progress of patients with high-grade T1 stage urothelial carcinoma of bladder after bladder-sparing operation

Transurethral Electric Resection Plus Arterial Catheterization Chemotherapy for T2a Bladder Carcinoma

Treatment strategy after a second transurethral resection for non-muscle invasive bladder cancer:immediate cystectomy or continued intravesical therapy

Advances in Combined Therapy with Bladder Preservation for Invasive Bladder Cancer

Long-term Outcomes of Combined Treatment of Bladder-Preserving Surgery and Adjuvant Intraarterial Chemotherapy for Patients with Stage T2 Bladder Cancer

The clinical investigation of different intravesical instillation of chemotherapy after transurethral resection of bladder tumors for the treatment of superficial bladder cancer